CAM
Cacti Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $168K | Hold |
10,000
| – | – | 0.01% | 67 |
|
|
2025
Q1 | $151K | Hold |
10,000
| – | – | 0.01% | 69 |
|
|
2024
Q4 | $223K | Hold |
10,000
| – | – | 0.02% | 63 |
|
|
2024
Q3 | $177K | Hold |
10,000
| – | – | 0.01% | 69 |
|
|
2024
Q2 | $163K | Hold |
10,000
| – | – | 0.01% | 68 |
|
|
2024
Q1 | $166K | Hold |
10,000
| – | – | 0.01% | 69 |
|
|
2023
Q4 | $105K | Hold |
10,000
| – | – | 0.01% | 72 |
|
|
2023
Q3 | $102K | Hold |
10,000
| – | – | 0.01% | 72 |
|
|
2023
Q2 | $75.3K | Hold |
10,000
| – | – | 0.01% | 73 |
|
|
2023
Q1 | $88.5K | Hold |
10,000
| – | – | 0.01% | 73 |
|
|
2022
Q4 | $91.2K | Hold |
10,000
| – | – | 0.01% | 73 |
|
|
2022
Q3 | $81K | Hold |
10,000
| – | – | 0.01% | 74 |
|
|
2022
Q2 | $75K | Hold |
10,000
| – | – | 0.01% | 77 |
|
|
2022
Q1 | $94K | Hold |
10,000
| – | – | 0.01% | 75 |
|
|
2021
Q4 | $80K | Hold |
10,000
| – | – | 0.01% | 73 |
|
|
2021
Q3 | $97K | Hold |
10,000
| – | – | 0.01% | 72 |
|
|
2021
Q2 | $104K | Hold |
10,000
| – | – | 0.01% | 72 |
|
|
2021
Q1 | $115K | Hold |
10,000
| – | – | 0.01% | 72 |
|
|
2020
Q4 | $96K | Hold |
10,000
| – | – | 0.01% | 73 |
|
|
2020
Q3 | $88K | Hold |
10,000
| – | – | 0.01% | 70 |
|
|
2020
Q2 | $127K | Hold |
10,000
| – | – | 0.01% | 66 |
|
|
2020
Q1 | $85K | Hold |
10,000
| – | – | 0.01% | 65 |
|
|
2019
Q4 | $100K | Sell |
10,000
-10,000
| -50% | -$100K | 0.01% | 69 |
|
|
2019
Q3 | $149K | Sell |
20,000
-666,543
| -97% | -$4.97M | 0.01% | 70 |
|
|
2019
Q2 | $6.18M | Sell |
686,543
-295,739
| -30% | -$2.66M | 0.48% | 27 |
|
|
2019
Q1 | $15.4M | Buy |
982,282
+404,378
| +70% | +$6.34M | 1.24% | 25 |
|
|
2018
Q4 | $8.91M | Buy |
577,904
+64,180
| +12% | +$990K | 0.78% | 27 |
|
|
2018
Q3 | $10.9M | Buy |
+513,724
| New | +$10.9M | 0.81% | 27 |
|